Satellos Bioscience Inc. (MSCLF)
OTCMKTS · Delayed Price · Currency is USD
0.4390
+0.0260 (6.30%)
Jul 11, 2025, 4:00 PM EDT

Satellos Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
759637726-
Upgrade
Market Cap Growth
115.45%160.46%440.53%-73.94%--
Upgrade
Enterprise Value
31793421-
Upgrade
Last Close Price
0.440.590.330.170.81-
Upgrade
PB Ratio
1.792.031.192.733.15-
Upgrade
P/TBV Ratio
1.792.031.32-9.86-
Upgrade
Debt / Equity Ratio
------5.95
Upgrade
Quick Ratio
15.3913.6711.080.772.575.12
Upgrade
Current Ratio
16.4414.1611.130.792.595.13
Upgrade
Return on Equity (ROE)
-61.24%-51.78%-72.15%-163.48%-301.13%-1404.79%
Upgrade
Return on Assets (ROA)
-33.91%-29.63%-38.28%-56.08%-43.45%-91.37%
Upgrade
Return on Capital (ROIC)
-36.67%-32.03%-43.89%-76.06%-52.31%-152.70%
Upgrade
Earnings Yield
-27.52%-20.42%-32.76%-123.13%-46.99%-
Upgrade
FCF Yield
-25.73%-18.15%-23.92%-61.40%-15.28%-
Upgrade
Buyback Yield / Dilution
-22.95%-32.84%-142.17%-48.20%-35.60%-62.72%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.